- Report
- February 2024
Greece
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
Ghana
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
Georgia
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
Finland
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
Estonia
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
El Salvador
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
Egypt
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
Ecuador
From €2551EUR$2,850USD£2,173GBP
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
Denmark
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
Czech Republic
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
Cyprus
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
Colombia
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
China
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
Chile
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
Canada
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
Bulgaria
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
Brazil
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
Bolivia
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
Belgium
From €2551EUR$2,850USD£2,173GBP

Immunofixation is a type of in vitro diagnostics (IVD) used to identify and quantify monoclonal immunoglobulins and light chains in serum and urine. It is a two-step process that involves the use of antibodies to separate and identify the components of a sample. The first step involves the use of a polyclonal antibody to separate the sample into its component parts. The second step involves the use of a monoclonal antibody to identify the components of the sample. Immunofixation is used to diagnose and monitor a variety of conditions, including multiple myeloma, Waldenström's macroglobulinemia, and amyloidosis.
The Immunofixation market is a rapidly growing segment of the IVD industry. It is driven by the increasing prevalence of chronic diseases, the growing demand for personalized medicine, and the need for accurate and timely diagnosis. Companies in the Immunofixation market include Abbott, Bio-Rad Laboratories, Siemens Healthineers, Ortho Clinical Diagnostics, and Thermo Fisher Scientific. Show Less Read more